BPS804 anti-sclerostin antibody in adults with moderate osteogenesis imperfecta: results of a randomized phase 2a trial - Glorieux, FH; Devogelaer, JP; Durigova, M (J Bone Miner Res, 2017)
. doi: 10.1002/jbmr.3143